Kaposi's sarcoma (KS) is a malignancy arising from vascular cells and characterized by the development of tumors on the skin, mucous membranes, and internal organs. It is most often associated with conditions that compromise the immune system, such as human immunodeficiency virus (HIV) infection. KS may present as purple or bluish-red spots and tumors on the skin, while systemic involvement may involve the lymphatic system, lungs, gastrointestinal tract, and other internal organs. The disease has various clinical forms, including classical, endemic, immunosuppressive, and epidemic, which highlights its diversity and complexity in diagnosis and treatment.
History of the disease and interesting historical facts
Kaposi's sarcoma was first described by the Hungarian dermatologist Moritz Kaposi in 1872. He called the disease "primary lymphosarcoma of the skin", not knowing its viral nature. In the early 1980s, synchronously with the HIV/AIDS epidemic, Kaposi's sarcoma began to receive wide attention due to its high incidence among patients with HIV. This led to the discovery of human herpes virus type 8 (HHV-8), which was established as the etiologic factor underlying most cases of KS. The uniqueness of the KS case is that it serves not only as an oncological disease, but also in many aspects of the public health calendar, raising discussions about the importance of immunity, social factors and inequalities in access to health care.
Epidemiology
According to the World Health Organization, the incidence of Kaposi's sarcoma varies in different regions of the world. In developed countries such as the United States and Europe, the disorder is most common in people with HIV and other conditions associated with immunosuppression. In Central and East African countries, the incidence is significantly higher, which is due to the endemic form of the disease. According to a study published in the journal Lancet Oncology, among patients with HIV, Kaposi's sarcoma has a prevalence of about 15-25 %. The increased incidence rates among men, especially in the age group from 40 to 60 years, emphasize the need for active control and monitoring of this pathology.
Genetic predisposition to this disease
Research shows that certain genetic factors and predispositions may influence the development of Kaposi's sarcoma. A study published in the Journal of Medical Virology describes a link between mutations in genes responsible for the immune response and an increased risk of developing KS. Key genes involved in the development of the disease include genes related to cytokine metabolism and genes regulating T-cell function. Such mutations may weaken the body's immune response, facilitating the spread of HHV-8 and the development of tumors.
Risk factors for the development of this disease
There are several factors that may contribute to the development of Kaposi's sarcoma:
- Presence of human herpes virus type 8 (HHV-8).
- Immunosuppression, including as a result of HIV infection, organ transplantation, or the use of immunosuppressive drugs.
- Age (the disease is more common in middle-aged men).
- Ethnicity (high incidence among Africans and Sephardic Jews).
- Chronic diseases affecting the immune status.
Diagnosis of this disease
Diagnosis of Kaposi's sarcoma includes the following methods:
- Clinical examination and assessment of symptoms: characteristic skin manifestations (papules, plaques, ulcers).
- Laboratory tests: determination of serological markers for HHV-8 and assessment of CD4 cell levels.
- Radiological examinations: ultrasound, computed tomography (CT) scan to assess internal lesions.
- Biopsy of the tumor for histological analysis.
- Differential diagnosis with other types of sarcomas and dermatological diseases.
Treatment
Treatment of Kaposi's sarcoma requires a comprehensive approach, including:
- General treatment: increasing immune activity, fighting HIV infection with antiretroviral therapy.
- Pharmacological treatment: use of chemotherapeutic drugs such as doxorubicin and vincristine.
- Surgical treatment: resection of tumors in localized forms of the disease.
- Other treatments: radiation therapy, interferon therapy.
List of medications used to treat this disease
The main drugs used to treat Kaposi's sarcoma include:
- Doxorubicin.
- Vincristine.
- Paclitaxel.
- Interferon alpha.
- Carbopladin.
Disease monitoring
Kaposi's sarcoma monitoring includes regular check-ups aimed at tracking the progression of the disease and identifying complications such as infections and bleeding. The prognosis of the disease varies depending on the patient's immune status and the stage of the tumor. With effective antiretroviral therapy and active treatment, Kaposi's sarcoma can be controlled for a long time. However, in advanced cases, the disease can lead to significant complications and increased mortality.
Age-related features of the disease
Kaposi's sarcoma may vary in its clinical presentation depending on the patient's age. Older people are more likely to have the classic form of KS, which is usually less aggressive, while younger people, especially those who are HIV-positive, often have the more aggressive epidemic form. In childhood, KS is rare and is often associated with immune disorders such as Down syndrome or other genetic abnormalities.
Questions and Answers
- What are the first signs of Kaposi's sarcoma? The first signs include the appearance of purple or red spots or plaques on the skin, which may progress painlessly and turn into tumors.
- What is the risk of developing Kaposi's sarcoma in patients with HIV? The risk is significantly increased, with an estimated 15-25% of HIV patients likely to develop the disease.
- Can Kaposi's sarcoma be cured? A complete cure is possible, but it depends on the stage of the disease, the state of the immune system and the response to treatment.
- What are the modern methods for diagnosing Kaposi's sarcoma? Modern diagnostics include clinical examination, laboratory tests for HHV-8, radiological studies and biopsy.
- How does HIV treatment affect the course of Kaposi's sarcoma? Effective antiretroviral therapy can significantly improve the prognosis and slow the progression of Kaposi's sarcoma.
Advice from Dr. Oleg Korzhikov
Kaposi's sarcoma, being a serious disease, requires a careful approach to diagnosis and treatment. It is important to conduct regular checks for HIV and other conditions that undermine the immune system. If characteristic skin manifestations such as purple spots or plaques occur, it is worth contacting a doctor for the necessary diagnostics. In addition, maintaining a strong immune system through a healthy lifestyle and regular medical monitoring can significantly reduce the risk of disease progression. Remember that timely referral to a specialist can save your life.
